REGN

Regeneron Pharmaceuticals, Inc. News Headlines

$414.3
*  
1.44
0.35%
Get REGN Alerts
*Delayed - data as of Jan. 28, 2015 13:02 ET  -  Find a broker to begin trading REGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    REGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Regeneron/Sanofi's PCSK9 Drug Gets FDA Priority Review - Analyst Blog
1/27/2015 6:50:00 PM - Zacks.com


Can Celgene (CELG) Beat Earnings on Strong Product Sales? - Analyst Blog
1/27/2015 4:45:00 PM - Zacks.com


Will Alexion's (ALXN) Soliris Drive Q4 Earnings Beat? - Analyst Blog
1/27/2015 3:20:00 PM - Zacks.com


Regeneron/Sanofi's PCSK9 Drug Gets FDA Priority Review - Analyst Blog
1/27/2015 6:50:00 AM - Investopedia


Can Celgene (CELG) Beat Earnings on Strong Product Sales? - Analyst Blog
1/27/2015 4:45:00 AM - Investopedia


Will Alexion's (ALXN) Soliris Drive Q4 Earnings Beat? - Analyst Blog
1/27/2015 3:20:00 AM - Investopedia


European Markets Indicate Weak Open After Syriza Victory In Greece
1/26/2015 2:53:00 AM - RTT News


FDA Grants Priority Review for Sanofi and Regeneron's Drug
1/26/2015 1:58:00 AM - Dow Jones Business News


Regeneron Pharma, Sanofi Say FDA Accepted For Priority Review BLA For Praluent
1/26/2015 1:10:00 AM - RTT News


Seeking Alpha's Biotech Weekly: Salix Sale Murmurs, A Very Active CHMP, And More
1/23/2015 4:00:00 PM - Seeking Alpha


Health Care Sector Update for 01/23/2015: REGN, ASPX, CELG
1/23/2015 8:42:32 AM - MT Newswires


Regeneron Pharma: EYLEA Injection Recommended For Approval By CHMP
1/23/2015 7:42:00 AM - RTT News


What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry
1/23/2015 7:30:00 AM - Seeking Alpha


S&P 500 Q4 Review: Utilities And Health Care Were The Top Sectors In 2014
1/22/2015 5:48:00 PM - Seeking Alpha


CAR-T Vs ErbB3 Market Opportunity Comparison
1/21/2015 1:32:00 PM - Seeking Alpha


Stock Market News for January 21, 2015 - Market News
1/21/2015 10:10:00 AM - Investopedia


The Week That Was: Healthcare Outlook Remains Excellent
1/20/2015 9:44:00 AM - Seeking Alpha


Alexion Pharmaceuticals Proves That Soliris Isn't Immune To Failure
1/20/2015 6:03:00 AM - Seeking Alpha


Amgen Will Deliver In 2015
1/15/2015 8:22:00 AM - Seeking Alpha


Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog
1/14/2015 2:39:00 PM - Investopedia


Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog
1/14/2015 2:39:00 PM - Zacks.com


Aegerion Reveals Preliminary 2014 Results and 2015 Outlook - Analyst Blog
1/13/2015 5:00:00 PM - Zacks.com


Express Scripts CEO: Amgen, Regeneron Among Targets for Drug Discounting
1/13/2015 12:46:00 PM - TheStreet


Regeneron Pharma To Present At J.P. Morgan Conference; Webcast At 1:30 PM ET
1/13/2015 12:30:00 PM - RTT News


Aegerion Reveals Preliminary 2014 Results and 2015 Outlook - Analyst Blog
1/13/2015 5:00:00 AM - Investopedia